Results 331 to 340 of about 331,561 (389)

Intravenous immunoglobulin (IVIG) in the vanguard therapy of Systemic Sclerosis.

Clinical Immunology, 2019
Systemic Sclerosis (SSc) is a rare autoimmune disease that is characterized by a progressive skin fibrosis, an obliteration of the microvasculature and an exaggerated extracellular matrix deposition, which lead to a multisystemic dysfunction.
J. Gomes, Lélita Santos, Y. Shoenfeld
semanticscholar   +1 more source

Intravenous Immunoglobulin Therapy in Dermatologic Disorders

Inflammation & Allergy-Drug Targets, 2008
Intravenous immunoglobulin (IVIG) is sterilized and purified human plasma which contains supra-physiologic levels of immunoglobulin G. IVIG is currently used in the treatment of immunodeficiency syndromes, inflammatory disorders and infectious diseases.
Seray Külcü, Cakmak, Ulker, Gül, Müzeyyen, Gönül, Arzu, Kiliç, Seçil, Soylu   +4 more
openaire   +2 more sources

Intravenous immunoglobulin therapy for Miller Fisher syndrome

Neurology, 2007
We analyzed clinical recovery of 92 patients with Miller Fisher syndrome who had been treated with IV immunoglobulin (IVIg; n = 28), plasmapheresis (n = 23), and no immune treatment (n = 41). IVIg slightly hastened the amelioration of ophthalmoplegia and ataxia, but the times of the disappearances of those symptoms were similar among three groups.
Masahiro, Mori, Satoshi, Kuwabara, Toshio, Fukutake, Takamichi, Hattori   +3 more
openaire   +2 more sources

Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis

Journal of the Neurological Sciences, 1999
We describe 4 patients with acute disseminated encephalomyelitis (ADEM) who were treated with intravenous immunoglobulins (IVIg) after getting no immediate response from a 3-5 day course of high dose intravenous methylprednisolone. All had clinical features to suggest poor prognosis and MRI findings to indicate extensive white matter changes in the ...
S, Pradhan, R P, Gupta, S, Shashank, N, Pandey   +3 more
openaire   +4 more sources

Intravenous Immunoglobulin Therapy for Neuromuscular Disorders

Seminars in Neurology, 2007
Treatment of specific immune-mediated neuromuscular disorders involves consideration of many factors including severity of illness, concurrent medical problems, supportive therapies, and immune-modulating therapies. Many immune-modulating therapies are available, including steroids, an increasing number of immunosuppressive drugs, plasmapheresis, and ...
openaire   +2 more sources

Intravenous Immunoglobulin in Therapy of Peripheral Neuropathy

Clinical Reviews in Allergy & Immunology, 2005
Peripheral neuropathy (PN) can be a manifestation of various neurological, infectious, metabolic, autoimmune, rheumatic, and malignant diseases. During the past decade, intravenous immunoglobulin (IVIg) has been increasingly used in the therapy of PN. Compared with other immunomodulatory therapies, IVIg has an excellent safety profile.
Alexander, Gorshtein, Yair, Levy
openaire   +2 more sources

Intravenous Immunoglobulin Therapy in Antiphospholipid Syndrome

Clinical Reviews in Allergy & Immunology, 2005
Antiphospholipid syndrome (APS) is an autoimmune disorder defined by the occurrence of venous and arterial thromboses and pregnancy morbidity, frequently accompanied by a moderate thrombocytopenia, in the presence of antiphospholipid antibodies. There is both laboratory and clinical evidence for the beneficial role of intravenous immunoglobulin (IVIg ...
openaire   +2 more sources

Home intravenous immunoglobulin therapy by self-administration

Journal of Clinical Immunology, 1986
Immunoglobulin replacement therapy is required by patients with certain antibody deficiency syndromes and is finding increasing application in other immune disorders such as immune thrombocytopenia. We describe the long-term home administration of intravenous gamma-globulin by seven patients themselves using a portable infusion pump.
E R, Ashida, A, Saxon
openaire   +2 more sources

Intravenous Immunoglobulin Therapy for Stevens-Johnson Syndrome

Southern Medical Journal, 2001
Stevens-Johnson syndrome (SJS) is an acute mucocutaneous disorder that can be associated with considerable morbidity. Several previous reports, all involving either adults with acquired immunodeficiency syndrome or children, suggest that intravenous immunoglobulin may be an effective treatment for SJS.
A S, Brett, D, Philips, A W, Lynn
openaire   +2 more sources

Intravenous immunoglobulin therapy for rheumatic diseases

Current Opinion in Rheumatology, 1994
Although clearly demonstrated in idiopathic thrombocytopenic purpura and Kawasaki disease, the efficacy of intravenous immunoglobulins in the treatment of rheumatic and connective tissue diseases remains to be confirmed in double-blind placebo-controlled studies.
openaire   +2 more sources